Activation of protein phosphatase 2A tumor suppressor as potential treatment of pancreatic cancer

We utilized three tiers of screening to identify novel therapeutic agents for pancreatic cancers. First, we analyzed 14 pancreatic cancer cell lines against a panel of 66 small‐molecule kinase inhibitors and dasatinib was the most potent. Second, we performed RNA expression analysis on 3 dasatinib‐r...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Mol Oncol
Egile Nagusiak: Chien, Wenwen, Sun, Qiao-Yang, Lee, Kian Leong, Ding, Ling-Wen, Wuensche, Peer, Torres-Fernandez, Lucia A., Tan, Siew Zhuan, Tokatly, Itay, Zaiden, Norazean, Poellinger, Lorenz, Mori, Seiichi, Yang, Henry, Tyner, Jeffrey W., Koeffler, H. Phillip
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley and Sons Inc. 2015
Gaiak:
Research Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4387089/
https://ncbi.nlm.nih.gov/pubmed/25637283
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molonc.2015.01.002
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak